CDKN2A and cancer: 15 out of 174 genes (Fig. 1B) that are up-regulated in both YAP1 S127A and KRAS G12V-Cdkn2a-null induced rhabdomyosarcoma overlap with top 100 genes whose high expression is best associated with poor survival in 18,000 cases of human cancer.